PMID- 31451768 OWN - NLM STAT- MEDLINE DCOM- 20191126 LR - 20221114 IS - 1476-4679 (Electronic) IS - 1465-7392 (Linking) VI - 21 IP - 9 DP - 2019 Sep TI - Protein kinase N controls a lysosomal lipid switch to facilitate nutrient signalling via mTORC1. PG - 1093-1101 LID - 10.1038/s41556-019-0377-3 [doi] AB - Mechanistic target of rapamycin (mTOR) kinase functions in two multiprotein complexes: lysosomal mTOR complex 1 (mTORC1) and mTORC2 at the plasma membrane. mTORC1 modulates the cell response to growth factors and nutrients by increasing protein synthesis and cell growth, and repressing the autophagy-lysosomal pathway(1-4); however, dysfunction in mTORC1 is implicated in various diseases(3,5,6). mTORC1 activity is regulated by phosphoinositide lipids(7-10). Class I phosphatidylinositol-3-kinase (PI3K)-mediated production of phosphatidylinositol-3,4,5-trisphosphate(6,11) at the plasma membrane stimulates mTORC1 signalling, while local synthesis of phosphatidylinositol-3,4-bisphosphate by starvation-induced recruitment of class II PI3K-beta (PI3KC2-beta) to lysosomes represses mTORC1 activity(12). How the localization and activity of PI3KC2-beta are regulated by mitogens is unknown. We demonstrate that protein kinase N (PKN) facilitates mTORC1 signalling by repressing PI3KC2-beta-mediated phosphatidylinositol-3,4-bisphosphate synthesis downstream of mTORC2. Active PKN2 phosphorylates PI3KC2-beta to trigger PI3KC2-beta complex formation with inhibitory 14-3-3 proteins. Conversely, loss of PKN2 or inactivation of its target phosphorylation site in PI3KC2-beta represses nutrient signalling via mTORC1. These results uncover a mechanism that couples mTORC2-dependent activation of PKN2 to the regulation of mTORC1-mediated nutrient signalling by local lipid signals. FAU - Wallroth, Alexander AU - Wallroth A AD - Leibniz-Forschungsinstitut fur Molekulare Pharmakologie (FMP), Berlin, Germany. FAU - Koch, Philipp A AU - Koch PA AD - Leibniz-Forschungsinstitut fur Molekulare Pharmakologie (FMP), Berlin, Germany. FAU - Marat, Andrea L AU - Marat AL AUID- ORCID: 0000-0001-8571-4253 AD - Leibniz-Forschungsinstitut fur Molekulare Pharmakologie (FMP), Berlin, Germany. FAU - Krause, Eberhard AU - Krause E AD - Leibniz-Forschungsinstitut fur Molekulare Pharmakologie (FMP), Berlin, Germany. FAU - Haucke, Volker AU - Haucke V AUID- ORCID: 0000-0003-3119-6993 AD - Leibniz-Forschungsinstitut fur Molekulare Pharmakologie (FMP), Berlin, Germany. haucke@fmp-berlin.de. AD - Faculty of Biology, Chemistry and Pharmacy, Freie Universitat Berlin, Berlin, Germany. haucke@fmp-berlin.de. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190826 PL - England TA - Nat Cell Biol JT - Nature cell biology JID - 100890575 RN - 0 (Lipids) RN - 0 (Multiprotein Complexes) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 2) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Cell Proliferation/physiology MH - Fibroblasts/metabolism MH - Humans MH - *Lipids MH - Lysosomes/*metabolism MH - Mechanistic Target of Rapamycin Complex 1/*metabolism MH - Mechanistic Target of Rapamycin Complex 2/metabolism MH - Multiprotein Complexes/metabolism MH - Phosphatidylinositol 3-Kinases/metabolism MH - Phosphorylation MH - Proto-Oncogene Proteins c-akt/metabolism MH - Signal Transduction/*physiology MH - TOR Serine-Threonine Kinases/metabolism EDAT- 2019/08/28 06:00 MHDA- 2019/11/27 06:00 CRDT- 2019/08/28 06:00 PHST- 2019/01/08 00:00 [received] PHST- 2019/07/19 00:00 [accepted] PHST- 2019/08/28 06:00 [pubmed] PHST- 2019/11/27 06:00 [medline] PHST- 2019/08/28 06:00 [entrez] AID - 10.1038/s41556-019-0377-3 [pii] AID - 10.1038/s41556-019-0377-3 [doi] PST - ppublish SO - Nat Cell Biol. 2019 Sep;21(9):1093-1101. doi: 10.1038/s41556-019-0377-3. Epub 2019 Aug 26.